Kubota Vision Inc. Signs Supply and Licensing Agreement with Laboratoires KÔL for Stargardt Disease Treatment Candidate Under Compassionate Use

Contributed by: Business Wire

Logo

Tags

Health

Other Health

Other Science

Research

Science

Pharmaceutical

Optical

Kubota Vision Inc.

More Like This

PR Newswire associated0

Global Registrational Phase III Study of Olverembatinib for the Treatment of Patients with SDH-Deficient GIST Approved by the China CDE

Théa Opens a New Chapter in Retinal Diseases

PR Newswire associated0

BioLab Holdings, Inc. Announces Strategic Investment in AI Diagnostic Technology

Celltrion Receives Positive CHMP Opinion for Three Biosimilars in the European Union

STADA and Calliditas announce the filing for full marketing authorization of Kinpeygo® in the EU

Celltrion Expands Biosimilar Portfolio in the European Union Following European Commission Approval of Two Biosimilars

Beacon Therapeutics Annouces Presentations at the ARVO 2026 Annual Meeting

AviadoBio and UgeneX Therapeutics Announce Exclusive Option-License Agreement to Develop Next Generation Optogenetics Gene Therapy to Restore Vision in Patients with Retinal Disease